ShankerValleau Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$413K Hold
344
0.11% 26
2026
Q1
$316K Hold
344
0.09% 31
2025
Q4
$370K Sell
344
-2
-0.6% -$1.91K 0.1% 28
2025
Q3
$264K Buy
346
+37
+12% +$27.5K 0.07% 35
2025
Q2
$241K Hold
309
0.07% 35
2025
Q1
$255K Hold
309
0.08% 32
2024
Q4
$239K Buy
+309
New +$256K 0.08% 33

Other funds holding LLY

ShankerValleau Wealth Advisors's LLY Position: Q2 2026 in Review

ShankerValleau Wealth Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 344 shares worth $413K. The position accounts for 0.11% of the portfolio, ranked #26.

ShankerValleau Wealth Advisors first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,405 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • ShankerValleau Wealth Advisors held 344 shares of Eli Lilly worth $413K as of Q2 2026.
  • ShankerValleau Wealth Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.11% of ShankerValleau Wealth Advisors's portfolio in Q2 2026, its #26 holding.
  • ShankerValleau Wealth Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 1,405 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on ShankerValleau Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.